GlyCardial Diagnostics
GlyCardial Diagnostics is a spin-off company of the IR-Hospital de la Santa Creu i Sant Pau and the Spanish National Research Council.
GlyCardial Diagnostics is active in the biotechnology, health care, health diagnostics, life science, medical device, pharmaceutical space based in European Union (EU), Europe, Middle East, and Africa (EMEA), founded in 2017.
Its activity falls under biotechnology, health care, health diagnostics, life science, medical device, pharmaceutical; the profile below is assembled from public directory data.
The company is recorded as being based in European Union (EU), Europe, Middle East, and Africa (EMEA).
Its current recorded stage is Grant.
Recorded headcount: c_00001_00010 employees.
It has disclosed roughly $4.4M in funding.
| Sector | Biotechnology, Health Care, Health Diagnostics, Life Science, Medical Device, Pharmaceutical |
|---|---|
| Headquarters | European Union (EU), Europe, Middle East, and Africa (EMEA) |
| Founded | 2017 |
| Employees | c_00001_00010 |
| Stage | grant |
| Total funding | $4,371,429 |
Website: www.glycardial.com
Browse related
Create a free account